Phase I/II multicentre trial of salvage chemotherapywith Gem-TIP for relapsed germ cell cancer.
Phase of Trial: Phase I/II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Gemcitabine (Primary) ; Chlorphenamine; Cisplatin; Dexamethasone; Filgrastim; Ifosfamide; Lenograstim; Mesna; Paclitaxel; Pegfilgrastim; Ranitidine
- Indications Germ cell and embryonal neoplasms
- Focus Adverse reactions; Therapeutic Use
- 22 Jan 2013 Planned end date changed from 31 Aug 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 03 Oct 2012 Accrual to date is 100% according to United Kingdom Clinical Research Network.
- 03 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.